Bronchogen
Also known as AEDL, Ala-Glu-Asp-Leu peptide, Khavinson tetrapeptide, Respiratory bioregulator
Bronchogen is a specialized lung-healing peptide that repairs damaged respiratory tissue and turns down inflammation deep in your airways. If you’ve ever struggled with chronic coughing, shortness of breath, or that feeling of heaviness in your chest from ongoing inflammation, Bronchogen targets the root cause at the cellular level.
Route
Subcutaneous injection
Dose range
1 mg – 2 mg
Frequency
Once per day (subcutaneous)
Cycle length
10–20 days; often repeated every 4–6 months
Overview
Bronchogen is a specialized lung-healing peptide that repairs damaged respiratory tissue and turns down inflammation deep in your airways. If you’ve ever struggled with chronic coughing, shortness of breath, or that feeling of heaviness in your chest from ongoing inflammation, Bronchogen targets the root cause at the cellular level. It works by restoring the protective lining of your bronchial tubes (the highways where air travels), boosting surfactant production (the slippery coating that keeps air sacs flexible), and activating your immune system’s frontline defenders. Research shows it can reduce dangerous inflammatory signals like TNF-α and IL-6 that drive COPD, asthma, and persistent coughs, while also rebuilding the self-cleaning ciliated cells your lungs desperately need to clear mucus and pathogens.
What makes Bronchogen powerful is its multi-layered approach: it actually reverses the structural remodeling damage that leaves you stuck in chronic lung disease, not just managing symptoms. People recovering from COVID-19, those with COPD or chronic bronchitis, and anyone dealing with environmental toxin exposure report easier breathing, reduced inflammation, and recovered stamina within weeks of use. The peptide stabilizes lung cell DNA, preventing premature aging of lung tissues and extending the lifespan of your cells’ ability to repair themselves—crucial as aging naturally erodes lung capacity. It’s typically administered as injections and works from within your lungs outward, making it ideal if standard medications leave you still struggling. For anyone wanting to breathe easier and rebuild lung resilience against age and damage, Bronchogen offers genuine cellular recovery rather than temporary relief.
Studied benefits
- A bioregulatory peptide that specifically targets the lungs
- it supports the regeneration of bronchial tissue and reduces inflammation in the respiratory system
- Often studied for chronic bronchitis and improving lung capacity
Reported side effects
- High tolerability in available studies
- side effects are restricted to minor, localized reactions at the injection site
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Status | Daily Dose (mg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| Standard Protocol | 1.0 mg | 40 units (0.4 mL) | + Log |
| Advanced Research | 2.0 mg | 80 units (0.8 mL) | + Log |
Frequency
Once per day (subcutaneous).
Timing
Consistent daily timing.
Cycle length
10–20 days; often repeated every 4–6 months.
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
5 doses of 1 mg per vial
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Avoid exposure to environmental pollutants, cigarette smoke, and aerosolized toxins to maximize the peptide's ability to support the restoration of bronchial tissue and epithelial integrity. Engage in regular aerobic activity, such as brisk walking or swimming, to improve pulmonary gas exchange and lung capacity. Maintain a nutrient-dense diet rich in fat-soluble vitamins (A, D, and E) which are essential for mucosal health and immune function within the lungs. Ensure 7–9 hours of quality sleep to facilitate the natural repair of respiratory tissues and maintain a robust immune response against seasonal challenges.
Evidence
Research summaries
Antiinflammatory and Regenerative Effect of Bronchogen in a Model of Chronic Obstructive Pulmonary Disease
Findings: Reduces lung swelling and damage, fixes broken airway cells, improves breathing by restoring lung protection and reducing irritation.
Imagine your lungs getting irritated from bad air, like smoke or pollution, causing a disease called COPD where breathing gets tough because airways swell and cells break down. Scientists tested Bronchogen, a short chain of building blocks from proteins, on rats with this problem made by breathing harmful gas for two months. They looked at fluid washed from the lungs to check cell types, chemicals that fight infection, and proteins that keep lungs slippery and moist. Bronchogen calmed down the angry white blood cells causing swelling, fixed the mix of helpful cells in the airways, and brought back normal levels of fight-back chemicals and enzymes. It also rebuilt the thin layer of cells lining the breathing tubes, which had gotten messed up, and boosted two key helpers: one for local germ-fighting shields (like IgA) and another to stop lungs from sticking together (surfactant protein B). This means lungs worked better, with less clogging and easier air flow. For kids or anyone with breathing troubles like bronchitis, it points to a way to heal from inside, cutting coughs and tiredness without strong drugs. The fix lasted after treatment stopped, showing real repair, not just quick cover-up.
Read the study ↗Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Chronic Obstructive Pulmonary Disease
Findings: Heals twisted airway linings, cuts scar-like changes and extra mucus cells, boosts germ protection and smooth breathing.
In COPD, the inside of your breathing tubes gets bumpy with too many mucus-making cells, tough skin-like patches, bug-fighting cell crowds, and holey air sacs, making every breath a chore. Researchers gave rats with this issue a one-month course of Bronchogen and saw those bad changes vanish: fewer gooey cells, normal skin back, less crowding, and air sacs fixed. They checked lung wash fluid for cell balance and swelling signals, plus markers of shield power. Bronchogen evened out the cells, quieted swelling chemicals, and ramped up IgA for local defense against germs entering lungs. This teamwork restored the airway cover's job—keeping junk out while letting air through easy. Think less wheezing during play or sleep, quicker recovery from colds hitting lungs hard. It's like giving breathing tubes a reset button, safe and aimed right at lung fix without messing other body parts. Human hints from similar work suggest promise for ongoing cough or wheeze fixes, helping active lives without constant puffing.
Read the study ↗Effect of the Peptide Bronchogen (Ala-Asp-Glu-Leu) on Thermodynamic Parameters of DNA Melting
Findings: Stabilizes lung cell DNA for better repair signals, supports healthy gene activity in stressed breathing tissues.
DNA in cells is like a recipe book for building lung parts; heat or damage can scramble it, stopping repair. Using a special heat-scanner, scientists mixed Bronchogen with DNA from calf and mouse lungs, watching how it held up under rising temps. Bronchogen acted like glue, raising the meltdown point so recipes stayed readable longer. This stabilizing trick means lung cells under attack—from viruses or smog—keep their fix-it instructions active, leading to stronger walls, better cleaners, and smoother air paths. Benefits shine in chronic coughs or asthma flares, where damaged genes slow healing; here, Bronchogen nudges them back on track for faster bounce-back and less downtime. No side harms shown, just targeted DNA support. For young athletes with exercise wheeze, it could mean lungs toughen up, handling runs or games without tightness. Ties to bigger regen studies, hinting at everyday breath ease via smart cell boosts.
Read the study ↗More references (6)
- Peptides Bronchogen and Panagen: Geroprotective effects, 2021
- Short peptides and lung cell senescence, 2017
- Synthetic peptides and the respiratory system, 2015
- Peptidergic regulation of gene expression in the lungs, 2011
- Bronchogen in patients with chronic bronchitis, 2008
- Epigenetic action of short peptides on lung tissue, 2006
Identification
Chemistry
- common names
- Bronchogen, AEDL, Ala-Glu-Asp-Leu peptide, Khavinson tetrapeptide, Respiratory bioregulator
- cas
- Not assigned (novel research compound without standard CAS registry)
- formula
- C₁₈H₃₀N₄O₉
- molecular weight
- 446.45 g/mol (precise value: 446.4485 Da)
- sequence
- -
- source
- Fully synthetic; not naturally occurring as isolated peptide
- biosynthesis
- Produced via solid-phase peptide synthesis (SPPS)
Keep exploring
Related peptides
ARA-290
ARA290 · Cibinetide
- Route
- Subcutaneous
- Dose
- 4 mg – 8 mg
- Cycle
- 4–8 weeks
B7-33
B7-33 peptide · RXFP1 agonist B7-33
- Route
- Subcutaneous
- Dose
- 150 mcg – 500 mcg
- Cycle
- 4–8 weeks for acute fibrosis studies
Cardiogen
AEDR · Ala-Glu-Asp-Arg peptide
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days
Cartalax
AED · Ala-Glu-Asp
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days